What is the ticker symbol for BioAtla?

BioAtla trades under the ticker BCAB on NASDAQ.

What sector does BioAtla operate in?

BioAtla is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze BCAB in a portfolio?

PortView shows BCAB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

BioAtla (BCAB) Stock Analysis

NASDAQHealthcareBiotechnology

$1.74+0.00%

1-year price historyRange $1.69 – $61.00

52-week range$1.74

$1.07$71.50

What BioAtla does

BioAtla Inc. is a biopharmaceutical firm currently in the clinical development phase, focused on creating highly specific and selective antibody-derived treatments designed to combat solid tumor cancers. The company's primary experimental therapeutic, BA3011, is a conditionally active biologic antibody-drug conjugate (CAB ADC) being investigated for its potential against soft tissue and bone sarcoma, non-small cell lung cancer (NSCLC), and ovarian cancer. Additionally, BioAtla is advancing BA3021, another CAB ADC, for a variety of solid malignancies such as NSCLC, melanoma, and ovarian cancer. A third candidate, BA3071, is a conditionally active anti-cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) antibody aimed at a broad spectrum of cancers, including renal cell carcinoma, non-small cell and small cell lung cancers, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. Established in 2007, BioAtla Inc. operates out of San Diego, California.

Key metrics

Market cap

$2.88M

P/E (TTM)

-0.12

EPS (TTM)

$-14.76

Beta

0.76

Dividend yield

0.00%

Revenue / share

$5.12

50-day avg

$3.44

200-day avg

$12.46

52-week high

$71.50

52-week low

$1.07

CEO

Jay Short

ETFs linked to BCAB

Broad-market and Healthcare sector ETFs an investor holding BioAtla is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how BCAB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BCAB in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for BioAtla?: BioAtla trades under the ticker BCAB on NASDAQ.
Which exchange is BCAB listed on?: BCAB is listed on NASDAQ.
What sector does BioAtla operate in?: BioAtla is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze BCAB in a portfolio?: PortView shows BCAB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.